Novozymes upgrades outlook on strong organic sales growth

COPENHAGEN, Oct 26 (Reuters) – Danish enzyme-maker Novozymes on Tuesday raised its full-year earnings outlook after seeing stronger sales growth and better earnings in the first nine months of the year, the company said in a statement.

Novozymes now expects full-year organic sales growth of 5%-6%, up from an August estimate of 4%-6%. It forecasts the earnings before interest and taxes (EBIT) margin to come in at around 27%, up from an earlier forecast of around 26%. (Reporting by Nikolaj Skydsgaard; Editing by Kirsten Donovan)

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html